US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 7.570
  • +0.090+1.20%
Close Oct 16 16:00 ET
  • 7.647
  • +0.077+1.01%
Post 20:01 ET
1.57BMarket Cap-10369P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioCryst Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 120.125M--
--2024/Q3-- / 113.999M--
Aug 5, 20242024/Q2109.332M / 98.324M--
May 6, 20242024/Q192.761M / 85.505M--
Feb 26, 20242023/Q493.401M / 89.995M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 120.125M--
--2024/Q3-- / 113.999M--
Aug 5, 20242024/Q2109.332M / 98.324M--
May 6, 20242024/Q192.761M / 85.505M--
Feb 26, 20242023/Q493.401M / 89.995M--

Unlock Free Earnings Estimates

BioCryst Pharmaceuticals Earnings Reports

  • BioCryst Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:09 ET

  • BioCryst Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 7 16:07 ET

  • BioCryst Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 27 16:16 ET

  • BioCryst Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 8, 2023 16:12 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 16, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data